BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2023 9:07:43 AM | Browse: 206 | Download: 543
 |
Received |
|
2023-06-25 02:49 |
|
Peer-Review Started |
|
2023-06-25 02:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-07-23 21:39 |
|
Revised |
|
2023-07-26 05:15 |
|
Second Decision |
|
2023-09-04 02:56 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-09-07 15:30 |
|
Articles in Press |
|
2023-09-07 15:30 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-09-20 00:17 |
|
Publish the Manuscript Online |
|
2023-09-25 09:07 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Scientometrics |
| Article Title |
Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023)
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jin-Jin Dai, Ya-Fei Zhang and Zhen-Hua Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Science Foundation of China |
No. 81273142 |
| Anhui Provincial Natural Science Foundation |
No. 2108085MH298 |
| University Scientific Research Project of Anhui Provincial Education Department |
No. KJ2021A0323 |
| Fund of Anhui Medical University |
No. 2021xkj196 |
| Clinical Medicine project of Anhui Medical University |
No. 2021LCXK027 |
| The Second Hospital of Anhui Medical University Natural Science Foundation |
No. 2019GMFY02 |
|
| Corresponding Author |
Zhen-Hua Zhang, MD, Professor, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Hefei 230601, Anhui Province, China. zzh1974cn@163.com |
| Key Words |
Bibliometrics; Treatment; Therapy; Nonalcoholic fatty liver disease; Metabolic dysfunction-associated fatty liver disease; Historiography analysis |
| Core Tip |
A total of 10829 articles published between 2010-2023 were identified through a bibliometric analysis to explore the trends and hotspots of treatment for nonalcoholic fatty liver disease (NAFLD). Replacing NAFLD/nonalcoholic steatohepatitis with metabolic dysfunction-associated fatty liver disease has been shown to greatly promote transformation of the treatment strategy of the disease. Research on gut microbiomes and traditional medicine will continue to be a short-term research hotspot. Obeticholic acid (phase 3 clinical validation) and semaglutide (under study) are likely to become the first approved drugs for NAFLD treatment. |
| Publish Date |
2023-09-25 09:07 |
| Citation |
Dai JJ, Zhang YF, Zhang ZH. Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023). World J Gastroenterol 2023; 29(37): 5339-5360 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i37/5339.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i37.5339 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
